Matches in Wikidata for { <http://www.wikidata.org/entity/Q62110305> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q62110305 description "clinical trial" @default.
- Q62110305 description "ensayu clínicu" @default.
- Q62110305 description "klinik çalışma" @default.
- Q62110305 description "klinisch onderzoek" @default.
- Q62110305 description "клінічне випробування" @default.
- Q62110305 description "临床试验" @default.
- Q62110305 name "Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment" @default.
- Q62110305 type Item @default.
- Q62110305 label "Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment" @default.
- Q62110305 prefLabel "Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment" @default.
- Q62110305 P1132 Q62110305-12EBDAB2-7227-4AC6-BF9C-274E5577E8F1 @default.
- Q62110305 P1476 Q62110305-FA7D05BD-40B8-4A96-BF79-9A57BAD57ACD @default.
- Q62110305 P17 Q62110305-033759D3-41AB-459A-B4A8-552D4D573C76 @default.
- Q62110305 P17 Q62110305-05897D7F-1E80-4E44-9D82-1A2C01A2488A @default.
- Q62110305 P17 Q62110305-06262F0E-8B37-4328-8214-FEF838FAC90C @default.
- Q62110305 P17 Q62110305-0D72F3C0-3360-4052-9F94-7A3BCD2C5773 @default.
- Q62110305 P17 Q62110305-20EEE849-5BB4-4919-A9BD-6BA65A8BF060 @default.
- Q62110305 P17 Q62110305-3649750F-7C81-49DD-AE6E-713828A862D7 @default.
- Q62110305 P17 Q62110305-38CC3110-A578-452F-9250-F3E53E9208FB @default.
- Q62110305 P17 Q62110305-520AD1CE-73EB-4DFB-81DE-D557A478A1B1 @default.
- Q62110305 P17 Q62110305-5D160740-EA7D-4648-A5CA-3DC90E97E775 @default.
- Q62110305 P17 Q62110305-7F312C68-89FA-4A23-A871-DD50DCE5C2D2 @default.
- Q62110305 P17 Q62110305-8F792C01-A9A2-4C98-A271-ED7A4E592446 @default.
- Q62110305 P17 Q62110305-A058C952-1452-41BB-A1DB-E6E66AC13030 @default.
- Q62110305 P17 Q62110305-B5A3C9C0-344B-4D7F-9890-07A3C17DA8C4 @default.
- Q62110305 P17 Q62110305-DEC91F5D-4C00-41F5-BB32-8FDED7FB9F8F @default.
- Q62110305 P3098 Q62110305-10F136C8-4D98-4325-8E7F-768BFB8B298D @default.
- Q62110305 P31 Q62110305-E7373EAF-BBC2-4BDE-9336-01C6DADC9E98 @default.
- Q62110305 P4844 Q62110305-0B33A330-4B31-4CEA-B9D5-BA16042760C5 @default.
- Q62110305 P4844 Q62110305-5AA6B7F5-C753-4673-B9CD-B8FB1811EDEB @default.
- Q62110305 P580 Q62110305-9B4B9A2E-D9D6-4121-99C8-71751184DF2D @default.
- Q62110305 P582 Q62110305-C99A5248-E2FD-45B4-879D-59B6C8F0427F @default.
- Q62110305 P6099 Q62110305-8C1D5C54-D551-41B9-8F6B-74E7D8D6ECBD @default.
- Q62110305 P6153 Q62110305-070F4425-EF81-4657-841B-B10724E7B752 @default.
- Q62110305 P8005 Q62110305-F65074C6-9230-4D9C-A6D4-1C880E4C1C02 @default.
- Q62110305 P8363 Q62110305-09F8F809-9801-4597-A7C7-0320D4319B9E @default.
- Q62110305 P859 Q62110305-61134655-B1F1-43D8-877F-0483312F951D @default.
- Q62110305 P1132 "+168" @default.
- Q62110305 P1476 "Phase II Multi-Center, Open-Label, Non-Randomized Study of Intravenous RPR109881 Given Every 3 Weeks in Patients With Metastatic Breast Cancer Progressing After Therapy With Anthracyclines, Taxanes and Capecitabine" @default.
- Q62110305 P17 Q142 @default.
- Q62110305 P17 Q16 @default.
- Q62110305 P17 Q183 @default.
- Q62110305 P17 Q258 @default.
- Q62110305 P17 Q29 @default.
- Q62110305 P17 Q30 @default.
- Q62110305 P17 Q31 @default.
- Q62110305 P17 Q35 @default.
- Q62110305 P17 Q38 @default.
- Q62110305 P17 Q39 @default.
- Q62110305 P17 Q414 @default.
- Q62110305 P17 Q43 @default.
- Q62110305 P17 Q55 @default.
- Q62110305 P17 Q739 @default.
- Q62110305 P3098 "NCT00087958" @default.
- Q62110305 P31 Q30612 @default.
- Q62110305 P4844 Q27116688 @default.
- Q62110305 P4844 Q420207 @default.
- Q62110305 P580 "2004-08-01T00:00:00Z" @default.
- Q62110305 P582 "2007-02-01T00:00:00Z" @default.
- Q62110305 P6099 Q42824440 @default.
- Q62110305 P6153 Q158205 @default.
- Q62110305 P8005 Q76651189 @default.
- Q62110305 P8363 Q78089383 @default.
- Q62110305 P859 Q158205 @default.